Clinical Trial Update: Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating zoledronate to prevent chemotherapy-induced bone loss in premenopausal women after breast cancer surgery; the study status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Osteoporosis

Drugs mentioned

• Zoledronate (zoledronic acid)

Snippet

Sponsor: Herbert Irving Comprehensive Cancer Center | Conditions: Breast Cancer, Osteoporosis | Phase 3 | Status: COMPLETED